|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001758,
umls-concept:C0023452,
umls-concept:C0027769,
umls-concept:C0221099,
umls-concept:C0282617,
umls-concept:C0542341,
umls-concept:C1513492,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1705994,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-12
|
|
pubmed:abstractText |
The objective was to evaluate whether motor nervous pathways are affected when patients are treated for childhood acute lymphoblastic leukemia (ALL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
345-51
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11241435-Adolescent,
pubmed-meshheading:11241435-Antineoplastic Agents,
pubmed-meshheading:11241435-Case-Control Studies,
pubmed-meshheading:11241435-Child,
pubmed-meshheading:11241435-Child, Preschool,
pubmed-meshheading:11241435-Evoked Potentials, Motor,
pubmed-meshheading:11241435-Female,
pubmed-meshheading:11241435-Humans,
pubmed-meshheading:11241435-Male,
pubmed-meshheading:11241435-Methotrexate,
pubmed-meshheading:11241435-Motor Neuron Disease,
pubmed-meshheading:11241435-Neurologic Examination,
pubmed-meshheading:11241435-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11241435-Vincristine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
|
|
pubmed:affiliation |
Department of Pediatrics, Oulu University Central Hospital, Oulu, Finland. Arja.Harila-Saari@oulu.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
